United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Healthcare Industry News Joe Hogan adds to Align stake with fresh $1m stock purchase, defying macro headwinds Align Technology CEO Joe Hogan purchases $1M in stock, signaling long-term confidence. Find out how this insider buy reflects broader digital dentistry trends. byPallavi MadhirajuAugust 3, 2025